VTCN1 (a T cell activation suppressor 1), also known as B7-H4, can regulate T cell activation in non-small-cell lung cancer [21], hepatocellular carcinoma [22], and prostate cancer [23]. Here, VTCN1 is linked to prostate carcinoma.